The relationship between pre-existing diabetes mellitus and the severity of acute pancreatitis: Report from a large international registry
Introduction
Acute pancreatitis (AP) is among the most common causes of gastrointestinal-related hospitalizations and its incidence has been increasing [1,2]. Although the overall mortality associated with AP is typically low, AP is associated with high morbidity, long-term sequelae, and substantial medical health care costs [[1], [2], [3]], especially among patients with greater severity of disease. Therefore, understanding the factors that contribute to AP severity is important.
Type 2 diabetes mellitus (DM) is a common medical condition affecting a significant proportion of adults in the US and it is associated with a 2–3 folds increase in the risk of AP [4,5]. Multiple factors appear to contribute to this increased risk. The risk is greater in patients with poorly controlled hyperglycemia and may be reduced by tighter glycemic control [6]. Other risk factors for AP are also more frequent in this population, such as obesity, gallstones, and hypertriglyceridemia [[7], [8], [9]]. Individuals with DM frequently have comorbidities that require treatment with medications, some of which can potentially cause AP [10].
Although pre-existing DM, i.e., diabetes mellitus present before AP, is a susceptibility risk factor, meaning has been associated with an increased risk for developing AP in observational studies [4,5], it is less clear if it also increases the severity of AP. In general, age and co-morbidities are risk factors for AP severity [11]. Individuals with pre-existing DM tend to be older and have a higher prevalence of comorbidities [9], and these confounders make it difficult to conclusively establish an independent association between pre-existing DM and AP severity. On the other hand, there is biological plausibility in the hypothesis that pre-existing DM might cause worse AP outcomes. Experimentally induced diabetes in mice causes aggravation of AP, with enhanced pancreatic inflammatory response, edema formation, and pulmonary injury [12,13].
A recent meta-analysis of 9 published studies concluded that pre-existing DM is associated with greater severity of AP [14]. The prevalence of pre-existing DM ranged from 12.6 to 26.8% and was associated with a greater risk of renal failure, need for and duration of intensive care unit (ICU) admission. However, there were several limitations of the studies included in the meta-analysis which affect the ability to accurately assess the relationship between pre-existing DM and AP severity. For example, of the 9 studies, only a subset assessed organ failure (n = 4), local complications (n = 3), or ICU admission (n = 3), and only one used the Revised Atlanta Classification [15] to evaluate disease severity. Therefore, the relationship between pre-existing DM and the severity of AP remains an unsettled question; in fact, this meta-analysis [14] emphasized the need for prospective studies to answer this question.
To establish whether pre-existing DM is indeed associated with AP severity, we investigated this potential relationship in a prospectively-ascertained cohort of patients with AP enrolled in the APPRENTICE study, which included 22 centers across 4 continents. Taking advantage of the large sample size of this cohort, the contribution of age, comorbidities, and other potential confounders could be examined.
Section snippets
Study cohort
The study population consisted of patients with AP enrolled in the Acute Pancreatitis Patient Registry to Examine Novel Therapies In Clinical Experience (APPRENTICE) registry from 22 centers across 4 continents (8 in the US, 6 in Europe, 5 in Latin American, 3 in India) from October 2015–January 2018. The study protocol was approved by the Institutional Review Board of the University of Pittsburgh (PRO15040389) and each of the study sites. The study was registered in clinicaltrials.gov
Baseline characteristics
A total of 1543 subjects with AP were enrolled in the APPRENTICE registry from October 2015 to January 2018. Of these, 487 (32%) were enrolled from North American, 396 (26%) from European, 361 (23%) from Indian, and 299 (19%) from Latin American centers. The mean (SD) age of patients was 49.6 (±18.5) with a male-to-female ratio of 1.1. The most common etiologies were gallstones (n = 697, 45%), alcoholic (n = 331, 21%), and idiopathic (n = 249, 16%).
Pre-existing DM in patients with AP
Pre-existing DM was observed in 17.5% of AP
Discussion
In this international registry with prospectively collected data from over 1500 subjects in four continents, we found that patients with pre-existing DM are more likely to be diagnosed with SIRS within 48h of admission and being admitted to an ICU, but also that the severity of AP (based on the Revised Atlanta Classification) was not different. Importantly, the association between pre-existing DM with SIRS and ICU admission was no longer present in multivariate analysis. Patients with DM were
Specific author contribution
DY developed the study concept and design. KJ, AH, and PP conducted data analysis. PP and DY drafted the manuscript. GIP, IP, RT, RK, MKG, AG, JAG, VKS, MFB, TS, STB, HN, SCG, NZ, LA, JJE, KT, MPL, ST, CO, EDM, GAC, BUW, PJL, DLC, PAH, and FGST contributed to the generation and collection of data, data interpretation, critical revision of the manuscript for important intellectual content. Final manuscript was approved by all authors.
Potential competing interest
None.
Acknowledgements
Research reported in this publication was supported under award numbers - U01 DK108306 (DY) by the National Cancer Institute (NCI) and NIDDK - U01DK108306 and U01DK127377(DY), the Department of Defense – DoD PR 182623 (DY), U01DK127388 (GIP, DLC), U01DK127400 (VKS), U01DK127377 (FGST), and NIH T32CA186873 (PP) training grant in cancer epidemiology and prevention. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National
References (24)
- et al.
Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018
Gastroenterology
(2019) - et al.
Diabetes mellitus and the risk of gallbladder disease: a systematic review and meta-analysis of prospective studies
J Diabet Complicat
(2016) - et al.
Severity and natural history of acute pancreatitis in diabetic patients
Pancreatology
(2015) - et al.
Co-morbidity is a strong predictor of early death and multi-organ system failure among patients with acute pancreatitis
J Gastrointest Surg
(2007) - et al.
Worldwide variations in demographics, management, and outcomes of acute pancreatitis
Clin Gastroenterol Hepatol
(2020) - et al.
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
J Chron Dis
(1987) - et al.
Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support
J Biomed Inf
(2009) - et al.
Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis
Pancreatology
(2006) - et al.
Global epidemiology and holistic prevention of pancreatitis
Nat Rev Gastroenterol Hepatol
(2019) - et al.
The incidence of acute pancreatitis: impact of social deprivation, alcohol consumption, seasonal and demographic factors
Aliment Pharmacol Ther
(2013)
Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes
Diabetes Obes Metabol
Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in Taiwan
Am J Gastroenterol
Cited by (5)
Acute Pancreatitis and Type 2 Diabetes Mellitus: The Chicken–Egg Paradox—A Seven-Year Experience of a Large Tertiary Center
2024, Journal of Clinical MedicineMechanisms linking hypertriglyceridemia to acute pancreatitis
2023, Acta PhysiologicaElevated serum HbA1c level, rather than previous history of diabetes, predicts the disease severity and clinical outcomes of acute pancreatitis
2023, BMJ Open Diabetes Research and Care